{"id":"https://openalex.org/W2402655812","doi":"https://doi.org/10.1097/fjc.0b013e3181dc61d4","title":"Cholesteryl Ester Transfer Protein Inhibition: A Dysfunctional Endothelium","display_name":"Cholesteryl Ester Transfer Protein Inhibition: A Dysfunctional Endothelium","publication_year":2010,"publication_date":"2010-03-26","ids":{"openalex":"https://openalex.org/W2402655812","doi":"https://doi.org/10.1097/fjc.0b013e3181dc61d4","mag":"2402655812","pmid":"https://pubmed.ncbi.nlm.nih.gov/20351566"},"language":"en","primary_location":{"id":"doi:10.1097/fjc.0b013e3181dc61d4","doi":"https://doi.org/10.1097/fjc.0b013e3181dc61d4","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0b013e3181dc61d4","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062340481","display_name":"Marit Westerterp","orcid":"https://orcid.org/0000-0003-2230-1659","observed_orcids":["https://orcid.org/0000-0003-2230-1659"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marit Westerterp","raw_affiliation_strings":["the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","The authors report no conflicts of interest"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"The authors report no conflicts of interest","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072268958","display_name":"Joris Koetsveld","orcid":"https://orcid.org/0000-0002-4604-5111","observed_orcids":["https://orcid.org/0000-0002-4604-5111"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joris Koetsveld","raw_affiliation_strings":["the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","The authors report no conflicts of interest"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"The authors report no conflicts of interest","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018642661","display_name":"Alan R. Tall","orcid":"https://orcid.org/0000-0002-7708-2417","observed_orcids":["https://orcid.org/0000-0002-7708-2417"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I78577930","display_name":"Columbia University","ror":"https://ror.org/00hj8s172","country_code":"US","type":"education","lineage":["https://openalex.org/I78577930"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan R Tall","raw_affiliation_strings":["the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","The authors report no conflicts of interest"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"From the Division of Molecular Medicine, Department of Medicine, Columbia University, New York, NY. E-mail: [email\u00a0protected]","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I78577930"]},{"raw_affiliation_string":"The authors report no conflicts of interest","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6421,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.72508238,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":95},"biblio":{"volume":"55","issue":"5","first_page":"456","last_page":"458"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8442000150680542,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.8442000150680542,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.04349999874830246,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12955","display_name":"Atherosclerosis and Cardiovascular Diseases","score":0.0215000007301569,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cholesteryl-ester-transfer-protein","display_name":"cholesteryl ester transfer protein","score":0.9710000157356262},{"id":"https://openalex.org/keywords/torcetrapib","display_name":"torcetrapib","score":0.9279999732971191},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cetp-inhibitors","display_name":"CETP inhibitors","score":0.722000002861023},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.6050000190734863},{"id":"https://openalex.org/keywords/illuminate-trial","display_name":"ILLUMINATE trial","score":0.8820000290870667},{"id":"https://openalex.org/keywords/anacetrapib","display_name":"anacetrapib","score":0.7210000157356262},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8109999895095825},{"id":"https://openalex.org/keywords/atherosclerosis","display_name":"atherosclerosis","score":0.6019999980926514},{"id":"https://openalex.org/keywords/off-target-effects","display_name":"off-target effects","score":0.6259999871253967},{"id":"https://openalex.org/keywords/cardiovascular-events","display_name":"cardiovascular events","score":0.4090000092983246},{"id":"https://openalex.org/keywords/hyperaldosteronism","display_name":"hyperaldosteronism","score":0.6679999828338623},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8920000195503235},{"id":"https://openalex.org/keywords/triglyceride-rich-lipoproteins","display_name":"triglyceride-rich lipoproteins","score":0.7429999709129333}],"concepts":[{"id":"https://openalex.org/C45505151","wikidata":"https://www.wikidata.org/wiki/Q424706","display_name":"Cholesterylester transfer protein","level":4,"score":0.8627365827560425},{"id":"https://openalex.org/C27502469","wikidata":"https://www.wikidata.org/wiki/Q906343","display_name":"Dysfunctional family","level":2,"score":0.6927288770675659},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5752401351928711},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.5344772934913635},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4271654486656189},{"id":"https://openalex.org/C3018928802","wikidata":"https://www.wikidata.org/wiki/Q83185","display_name":"Gene transfer","level":3,"score":0.4136698246002197},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.29913759231567383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.296953022480011},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28281864523887634},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.18925270438194275},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.09547671675682068},{"id":"https://openalex.org/C70410870","wikidata":"https://www.wikidata.org/wiki/Q199906","display_name":"Clinical psychology","level":1,"score":0.06365931034088135},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.053393155336380005}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D053480","descriptor_name":"Cholesterol Ester Transfer Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1097/fjc.0b013e3181dc61d4","doi":"https://doi.org/10.1097/fjc.0b013e3181dc61d4","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0b013e3181dc61d4","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:20351566","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20351566","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Editorial"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/c9d65d7d-3cbf-4097-b699-21106d86f48e","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/c9d65d7d-3cbf-4097-b699-21106d86f48e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Westerterp, M, Koetsveld, J & Tall, A R 2010, 'Cholesteryl ester transfer protein inhibition : a dysfunctional endothelium', Journal of Cardiovascular Pharmacology, vol. 55, no. 5, pp. 456-458. https://doi.org/10.1097/FJC.0b013e3181dc61d4","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/c9d65d7d-3cbf-4097-b699-21106d86f48e","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/c9d65d7d-3cbf-4097-b699-21106d86f48e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Cardiovascular Pharmacology, 55(5), 456 - 458","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1973355122","https://openalex.org/W1973740761","https://openalex.org/W1975348263","https://openalex.org/W1984820374","https://openalex.org/W1992547254","https://openalex.org/W2000280951","https://openalex.org/W2028996226","https://openalex.org/W2038937780","https://openalex.org/W2048760408","https://openalex.org/W2063992255","https://openalex.org/W2073236176","https://openalex.org/W2101396854","https://openalex.org/W2104297893","https://openalex.org/W2106624199","https://openalex.org/W2127996877","https://openalex.org/W2131620609","https://openalex.org/W2134811220","https://openalex.org/W2135459459","https://openalex.org/W2137113092","https://openalex.org/W2141210634","https://openalex.org/W2155905764","https://openalex.org/W2164934684","https://openalex.org/W2171411731"],"related_works":["https://openalex.org/W2187412430","https://openalex.org/W2009220054","https://openalex.org/W2003803208","https://openalex.org/W1973014196","https://openalex.org/W1985322784","https://openalex.org/W2128055643","https://openalex.org/W1973440575","https://openalex.org/W2127608622","https://openalex.org/W4273006","https://openalex.org/W2020241535"],"abstract_inverted_index":{"Written":[0],"as":[1,158,172,324,342,617,897,934,1100],"an":[2,141,382,456,834,1028,1315],"editorial":[3],"commentary":[4],"regarding":[5],"Connelly":[6,756,818,872,1159,1329],"et":[7,757,819,873,1160,1330],"al,":[8],"Torcetrapib":[9,99,566,748,929],"Produces":[10],"Endothelial":[11,910],"Dysfunction":[12],"Independent":[13],"of":[14,23,40,121,140,143,169,205,225,258,263,273,339,363,406,411,451,462,486,496,527,535,597,604,622,684,712,722,732,747,795,814,838,846,849,878,937,961,976,987,1005,1057,1066,1085,1092,1103,1123,1142,1150,1158,1170,1201,1256,1273,1294,1336],"Cholesteryl":[15],"Ester":[16],"Transfer":[17],"Protein":[18],"Inhibition,":[19],"on":[20,632,686,728,798,1152,1172,1275,1339],"pages":[21],"459-468":[22],"the":[24,38,101,116,149,179,182,192,202,220,234,244,261,331,348,361,364,369,391,404,452,460,466,471,483,497,514,595,609,649,682,710,719,729,776,781,785,793,812,831,864,876,899,903,907,927,972,1003,1017,1031,1051,1058,1064,1069,1083,1090,1121,1148,1156,1168,1199,1202,1219,1232,1237,1260,1271,1295,1304,1318,1323,1334],"journal.":[25],"The":[26,76,692,726,894,1326],"cholesteryl":[27,41],"ester":[28,42],"transfer":[29,34],"protein":[30],"(CETP)":[31],"is":[32,62,708,912,924,1227],"a":[33,63,159,290,583,620,641,663,915,935,1101,1178,1188,1253],"factor":[35],"that":[36,198,228,394,424,521,530,644,760,770,792,822,840,923,998,1088,1139,1184,1306,1333],"mediates":[37,974],"exchange":[39],"and":[43,50,54,71,86,94,145,174,196,278,282,295,299,310,334,465,538,576,580,634,657,678,703,737,751,768,886,1037,1147,1221,1259],"triglycerides":[44],"between":[45,459,629,675],"triglyceride-rich":[46],"lipoproteins":[47],"(ie,":[48],"chylomicrons":[49],"very":[51],"low-density":[52,88,312],"lipoprotein)":[53],"high-density":[55],"lipoprotein":[56,89,313],"(HDL)":[57],"in":[58,92,97,108,111,129,148,208,250,254,330,347,368,384,387,396,409,470,482,504,525,533,600,608,648,668,699,716,734,741,749,766,780,784,830,906,984,1034,1040,1053,1063,1082,1155,1207,1322],"plasma.1":[59],"CETP":[60,77,103,193,276,292,610,650,655,796,809,883,1337,1350],"inhibition":[61,845,1293],"potential":[64],"therapeutic":[65],"strategy":[66],"to":[67,105,125,135,161,200,217,243,270,381,588,775,827,880,898,914,957,995,1002,1014,1074,1113,1120,1130,1194,1213,1242,1266,1282,1289,1352],"raise":[68],"HDL":[69,83,279,308,392,426,440,468,487,511,528,546,554,560,601,615,633,659,676],"levels":[70,85,91,469,489,512,660],"treat":[72,162,1353],"cardiovascular":[73,146,184,366,502,778,1320],"disease":[74,478],"(CVD).":[75],"inhibitor":[78,104],"torcetrapib":[79,150,153,170,206,226,247,306,472,508,522,625,685,733,761,823,879,1151,1247,1274,1285,1300,1307],"dose":[80,621],"dependently":[81],"increased":[82,183,307,365,571,577,694,777,1214,1319],"cholesterol":[84,90,309,314,413,420,430,488,536],"decreased":[87,95,311,574,1075],"humans2":[93],"atherosclerosis":[96,323,341],"rabbits.3":[98],"was":[100,154,248,378,480,568,586,697,841,869],"first":[102],"be":[106,136,231,594,802,1243,1264,1280,1343],"tested":[107,249],"clinical":[109,211,304],"trials":[110,257],"combination":[112,251],"with":[113,233,252,289,445,507,552,570,613,619,653,662,705,853,993,1011,1050,1111,1187],"atorvastatin.":[114],"Unexpectedly,":[115],"large":[117,401,559,916],"phase":[118,209],"3":[119,210,255],"Investigation":[120,262],"Lipid":[122,264],"Level":[123,265],"Management":[124,266],"Understand":[126],"its":[127,964],"Impact":[128],"Artherosclerotic":[130],"Events":[131],"(ILLUMINATE)":[132],"trial":[133,454,499],"had":[134],"ended":[137],"prematurely":[138],"because":[139],"excess":[142],"deaths":[144],"events":[147,185,367,503,779,1321],"group.4":[151],"Thus,":[152,351,681],"not":[155,188,319,356,379,842,870,890,1132],"further":[156,218,1254],"developed":[157],"drug":[160],"CVD.":[163,815,1354],"Even":[164],"though":[165],"various":[166],"off-target":[167,730],"toxicities":[168,204,224],"such":[171],"hypertension":[173,723],"hyperaldosteronism":[175],"have":[176,773],"been":[177,416,1137,1182],"identified,4":[178],"reasons":[180],"for":[181,811,902,1030,1317],"are":[186,207,689,739,1038,1144,1162],"still":[187,1287],"completely":[189],"clear.":[190],"Because":[191,390],"inhibitors":[194,797,810,884,1338,1351],"JTT-705":[195],"anacetrapib":[197],"appear":[199],"lack":[201],"known":[203],"development,":[212],"it":[213,377,1135],"remains":[214,724,896,1241],"vitally":[215],"important":[216],"unravel":[219],"mechanisms":[221,1025,1128,1166,1262],"underlying":[222,1261],"vascular":[223,764,865],"so":[227],"these":[229,352,407,425,446,518,557,591,1140],"can":[230],"evaluated":[232],"newer":[235],"agents.":[236],"ON-TARGET":[237],"EFFECTS":[238,563],"OF":[239,564],"TORCETRAPIB":[240,565],"In":[241,302,418,816,970,1107],"addition":[242],"ILLUMINATE":[245,370,498,786,1324],"trial,":[246,371],"atorvastatin":[253],"imaging":[256,353],"similar":[259,614,673],"design:":[260],"Using":[267],"Coronary":[268],"Ultrasound":[269],"Assess":[271],"Reduction":[272],"Atherosclerosis":[274],"by":[275,287,326,344,844,918,926,1060],"Inhibition":[277],"Elevation":[280],"(ILLUSTRATE)":[281],"Rating":[283],"Atherosclerotic":[284],"Disease":[285],"Change":[286],"Imaging":[288],"New":[291],"Inhibitor":[293],"1":[294,298,333],"2":[296,335,881],"(RADIANCE":[297],"2)":[300],"trials.5-7":[301],"all":[303,861],"trials,":[305],"levels.4-7":[315],"However,":[316,718,857],"this":[317,754,771,789],"did":[318,355,889],"significantly":[320],"affect":[321,891],"carotid":[322,327],"measured":[325,343],"intima-media":[328],"thickness":[329],"RADIANCE":[332],"trials5,6":[336],"or":[337,637,1009],"progression":[338],"coronary":[340],"intravascular":[345],"ultrasound":[346],"ILLUSTRATE":[349,453],"trial.7":[350],"results":[354,1062,1081],"provide":[357,1027,1314],"definite":[358],"insights":[359],"into":[360,804,1270,1345],"cause":[362],"but":[372],"at":[373,544,963,1016,1068],"least":[374],"they":[375],"suggested":[376],"due":[380],"increase":[383],"measurable":[385],"increases":[386,599,616,677],"plaque":[388,542],"size.":[389],"particles":[393,408,427,529],"accumulated":[395],"torcetrapib-treated":[397,782,908,1035],"patients":[398,505],"were":[399,531],"relatively":[400,1163],"cholesterol-enriched":[402,558],"particles,2":[403],"functionality":[405],"terms":[410,534],"inducing":[412],"efflux":[414,421,431,537],"has":[415,1136,1181],"questioned.":[417],"fact,":[419],"studies":[422,671,727],"showed":[423,500,626,672,821],"induced":[428],"more":[429,1229],"via":[432,951,1236,1298],"adenosine":[433],"triphosphate-binding":[434],"cassette":[435],"transporter":[436],"G1":[437],"(ABCG1)":[438],"than":[439,1231],"from":[441,556,1328],"control":[442],"patients.8":[443],"Consistent":[444],"observations,":[447],"post":[448],"hoc":[449,494],"analyses":[450,495],"revealed":[455],"inverse":[457],"relationship":[458],"percent":[461],"atheroma":[463],"volume":[464],"achieved":[467],"group":[473,783],"(P":[474,490],"<":[475,491],"0.001).7":[476],"Moreover,":[477,640,788],"regression":[479],"observed":[481],"highest":[484],"quartile":[485],"0.01).7":[492],"Post":[493],"fewer":[501],"treated":[506],"who":[509],"exhibited":[510],"above":[513],"median.4":[515],"Taken":[516,1251],"together,":[517,1252],"data":[519,549,1327],"suggest":[520,769],"treatment":[523,567,813,824,859,1286],"resulted":[524],"formation":[526,1004,1122],"functional":[532],"could":[539,593,772,1026,1175,1312],"perhaps":[540],"reduce":[541],"burden":[543],"higher":[545,658],"levels.":[547,602,940],"These":[548,1024,1127],"seem":[550],"inconsistent":[551],"direct":[553],"toxicity":[555],"particles.":[561],"OFF-TARGET":[562],"associated":[569,612,652],"blood":[572,635,687,695],"pressure,":[573],"potassium":[575],"sodium":[578,1204],"levels,":[579],"hyperaldosteronism.4-7":[581],"Recently,":[582],"genetic":[584],"approach":[585],"used":[587],"determine":[589],"if":[590],"effects":[592,631,683,731,794,877,1141,1149,1169,1272,1335],"consequence":[596,711,936,1102],"CETP-mediated":[598,630],"Carriers":[603],"single":[605,645],"nucleotide":[606,646],"polymorphisms":[607,647],"gene":[611,651],"compared":[618,875],"10":[623],"mg":[624],"no":[627],"association":[628],"pressure":[636,688,696],"electrolyte":[638],"levels.9":[639],"meta-analysis":[642],"indicated":[643],"lower":[654],"activities":[656],"correlated":[661,704],"small,":[664],"although":[665],"significant,":[666],"reduction":[667],"CVD.10":[669],"Prospective":[670],"correlations":[674],"CVD":[679],"risk.10":[680],"compound":[690],"specific.":[691],"torcetrapib-mediated":[693],"confirmed":[698],"several":[700,952],"animal":[701,735],"studies11-13":[702],"hyperaldosteronism,11,12":[706],"which":[707,947,1197,1217,1299],"likely":[709],"torcetrapib-induced":[713],"Ca2+":[714,1195],"influx":[715],"adrenals.14":[717],"exact":[720],"mechanism":[721,900],"elusive.":[725],"models":[736],"cells":[738,1220],"summarized":[740,1039],"Table":[742],"1.TABLE":[743],"1:":[744,1043],"Adverse":[745],"Effects":[746],"Animal":[750],"Cell":[752],"StudiesIn":[753],"issue,":[755],"al16":[758,820,874,1161],"reported":[759],"impairs":[762],"endothelium-dependent":[763],"relaxation":[765],"rabbits":[767,1036],"contributed":[774],"trial.":[787,1325],"result":[790],"suggests":[791],"endothelial":[799,847,892,904,1032,1054,1173,1208,1276,1290,1310,1340],"function":[800,868,911,1174,1311,1341],"should":[801,1342],"taken":[803,1344],"account":[805,1346],"when":[806,1347],"evaluating":[807,1348],"novel":[808,1349],"addition,":[817,971,1108],"also":[825,1080,1176],"led":[826],"basal":[828],"vasoconstriction":[829],"aorta,":[832],"suggesting":[833,863],"additional":[835],"adverse":[836],"effect":[837,1226],"torcetrapib,":[839],"mimicked":[843],"isoform":[848],"NO":[850,994,1112,1131,1223],"synthase":[851],"(eNOS)":[852],"l-nitro-arginine":[854],"methyl":[855],"ester.":[856],"nitroprusside":[858],"reversed":[860],"abnormalities":[862],"smooth":[866],"muscle":[867],"impaired.16":[871],"other":[882,1165],"JNJ-28545595":[885],"JNJ-28614872":[887],"those":[888],"function.":[893,1277],"question":[895],"responsible":[901],"dysfunction":[905,1033,1291],"rabbits.":[909],"affected":[913],"extent":[917],"nitric":[919],"oxide":[920],"(NO)":[921],"bioavailability":[922],"produced":[925],"eNOS.17":[928],"might":[930],"modulate":[931],"eNOS":[932,949,962,1007,1012,1046,1067,1076,1098,1125,1249,1257],"activity":[933,950,1047,1099,1258],"increasing":[938],"aldosterone":[939,1061,1143,1171,1185,1233],"Aldosterone":[941,1044],"activates":[942],"mineralocorticoid":[943],"receptor":[944],"(MR)":[945],"signaling,":[946],"inhibits":[948],"pathways.":[953],"MR":[954,973,1052,1059,1078],"activation":[955,975,1079,1200,1211],"leads":[956,1212,1288],"phosphatase":[958],"2A-mediated":[959],"dephosphorylation":[960,1065],"major":[965],"phosphorylation-activation":[966],"site":[967],"serine":[968],"1177.18,19":[969],"nicotinamide":[977],"adenine":[978],"dinucleotide":[979],"phosphate":[980],"(NADPH)":[981],"oxidases,18,19":[982],"resulting":[983],"enhanced":[985],"production":[986,1091],"reactive":[988,1093],"oxygen":[989,1094],"species.":[990,1095],"Superoxides":[991,1096],"interact":[992,1010,1110],"form":[996,1114],"peroxynitrites":[997],"uncouple":[999],"eNOS,":[1000,1118],"leading":[1001,1013,1073,1119,1193],"inactive":[1006,1124],"monomers20":[1008],"phosphorylation":[1015],"tyrosine":[1018],"657":[1019,1105],"residue,":[1020],"thereby":[1021],"inactivating":[1022],"eNOS.21":[1023],"explanation":[1029,1316],"Figure":[1041],"1.FIGURE":[1042],"decreases":[1045,1222],"upon":[1048,1292],"interaction":[1049],"cells.":[1055,1209],"Activation":[1056],"Ser":[1070],"1177":[1071],"site,":[1072],"activity.":[1077,1250],"induction":[1084],"NADPH":[1086],"oxidases":[1087],"enhance":[1089],"inhibit":[1097],"Tyr":[1104],"phosphorylation.":[1106],"superoxides":[1109],"peroxynitrite.":[1115],"Peroxynitrite":[1116],"uncouples":[1117],"monomers.":[1126],"lead":[1129],"being":[1133],"produced.Because":[1134],"proposed":[1138],"rather":[1145],"slow22,23":[1146],"acetylcholine-mediated":[1153],"vasodilation":[1154],"study":[1157],"acute,":[1164],"mediating":[1167],"play":[1177],"role.":[1179],"It":[1180,1239,1278],"postulated":[1183],"interacts":[1186],"yet":[1189],"unidentified":[1190],"membrane":[1191],"receptor,":[1192],"influx,":[1196],"triggers":[1198],"epithelial":[1203],"channels":[1205],"(ENaC)":[1206],"This":[1210,1225],"intracellular":[1215],"sodium,":[1216],"\u201cstiffens\u201d":[1218],"production.22,23":[1224],"apparently":[1228],"acute":[1230],"pathways":[1234],"mediated":[1235],"MRs.":[1238],"however":[1240],"determined":[1244],"exactly":[1245],"how":[1246],"affects":[1248,1309],"evaluation":[1255],"may":[1263],"desirable":[1265],"obtain":[1267],"deeper":[1268],"insight":[1269],"would":[1279],"interesting":[1281],"evaluate":[1283],"whether":[1284],"renin-angiotensin-aldosterone":[1296],"system":[1297],"induces":[1301],"hyperaldosteronism.":[1302],"Nevertheless,":[1303],"observation":[1305],"adversely":[1308],"potentially":[1313],"al":[1331],"indicate":[1332]},"counts_by_year":[{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}